Xylem Accrued liabilities remained flat by 0.0% to -$17.25M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 505.9%, from $4.25M to -$17.25M. Over 4 years (FY 2021 to FY 2025), Accrued liabilities shows a downward trend with a 77.2% CAGR.
Fluctuations reflect changes in the timing of operational expense recognition and payment cycles.
This represents the net change in short-term obligations for expenses that have been incurred but not yet invoiced or pa...
Standard line item in the operating section of the cash flow statement.
other_increase_decrease_in_accrued_liabilities| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $7.00M | $57.00M | -$4.00M | $17.00M | -$69.00M |
| YoY Change | — | +714.3% | -107.0% | +525.0% | -505.9% |